Born from innovative research at Case Western Reserve University by Professors Paul Tesar, PhD, and Drew Adams, PhD, Convelo Therapeutics is ushering in a new era of multiple sclerosis care. Our patented remyelination enhancing therapies offer more than hope – they promise tangible repair and renewal for those living with MS.  Partnering with leading academic and medical institutions, we’re pioneering a future where MS doesn’t just pause – it retreats.